Compound information
- Natural Products
- ZC1949860
- Molecular Formula
- C16H23BrN2O4S
- Molecular Weight
- 418.056190316 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-bromophenyl)sulfonyl-1,4-diazepane-1-carboxylate
- InChI
- InChI=1S/C16H23BrN2O4S/c1-16(2,3)23-15(20)18-9-4-10-19(12-11-18)24(21,22)14-7-5-13(17)6-8-14/h5-8H,4,9-12H2,1-3H3
- InChI Key
- RWITZYGOTODACS-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCCN(S(=O)(=O)c2ccc(Br)cc2)CC1
- Source
- ZINC000066322922
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.343 |
LogS | -4.308 | LogD | 3.787 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.047 | Pgp substrate | 0.016 |
HIA | 0.974 | F20 % | 0.993 |
F30 % | 0.973 | Caco-2 | -4.381 |
MDCK | -4.845 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.978 | PPB | 94.602 |
VD | 1.943 | Fu | 0.79 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.138 | CYP1A2 substrate | 0.523 |
CYP2A6 substrate | 0.685 | CYP2B6 substrate | 0.677 |
CYP2C19 inhibitor | 0.941 | CYP2C19 substrate | 0.842 |
CYP2C8 substrate | 0.67 | CYP2C9 inhibitor | 0.673 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.288 |
CYP2D6 substrate | 0.921 | CYP2E1 substrate | 0.889 |
CYP3A4 inhibitor | 0.199 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.275 | CL | 6.227 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.917 | Hepatotoxicity | 0.999 |
Mutagenicity | 0.189 | Rat Oral Acute Toxicity | 0.152 |
FDAMDD | 0.103 | Skin Sensitization | 0.074 |
Carcinogenicity | 0.853 | Eye Corrosion | 0.132 |
Eye Irritation | 0.071 | Respiratory Toxicity | 0.819 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.649 | IGC50 | 3.588 |
LC50FM | 3.227 | LC50DM | 4.195 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.2 | NR-AR-LBD | 0.286 |
NR-AhR | 0.034 | NR-Aromatase | 0.483 |
NR-ER | 0.254 | NR-ER-LBD | 0.408 |
NR-PPAR-gamma | 0.124 | SR-ARE | 0.769 |
SR-ATAD5 | 0.378 | SR-HSE | 0.093 |
SR-MMP | 0.055 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.